Effects of induction therapy with alemtuzumab versus antithymocyte globulin among highly sensitized kidney transplant candidates
المؤلفون المشاركون
Shamsaifar, Ali Rida
Khajerezae, Thurayya
Nikeghbalian, Saman
Mutazz al-Din, Nisrin
Kazimi, Kourosh
Geramizadeh, Bita
Roozbeh, Jamshid
Malik Husayni, Sayyid Ali
المصدر
Saudi Journal of Kidney Diseases and Transplantation
العدد
المجلد 27، العدد 4 (31 أغسطس/آب 2016)، ص ص. 665-670، 6ص.
الناشر
تاريخ النشر
2016-08-31
دولة النشر
السعودية
عدد الصفحات
6
التخصصات الرئيسية
الموضوعات
الملخص EN
We retrospectively compared induction therapy utilizing alemtuzumab and antithymoglobulin (ATG) in high-risk kidney transplant recipients in our center.
Two hundred and fifty-one patients underwent kidney transplantation between 2009 and 2012.
The high-risk patients were defined as those who had two or more times kidney transplantation and/or more than 30% panel reactive antibody.
We studied 130 high-risk kidney transplant candidate; 58 (44.6%) patients received induction immunosuppressive therapy with alemtuzumab, and 72 (55.4%) with ATG.
Delayed graft function developed in 11 patients receiving alemtuzumab, against the 27 patients who receiving ATG (P = 0.021).
Acute cellular rejection episodes were observed in five patients in the alemtuzumab group and 19 patients in the ATG group (P = 0.009).
There were three graft failures in the alemtuzumab group and eight graft failures in the ATG group due to rejection episodes.
We found immunosuppressive induction therapy with alemtuzumab a significantly less incidence of acute rejection and delayed graft function than induction therapy with ATG in the high-risk kidney transplant recipients.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Shamsaifar, Ali Rida& Roozbeh, Jamshid& Khajerezae, Thurayya& Nikeghbalian, Saman& Kazimi, Kourosh& Malik Husayni, Sayyid Ali…[et al.]. 2016. Effects of induction therapy with alemtuzumab versus antithymocyte globulin among highly sensitized kidney transplant candidates. Saudi Journal of Kidney Diseases and Transplantation،Vol. 27, no. 4, pp.665-670.
https://search.emarefa.net/detail/BIM-693015
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Malik Husayni, Sayyid Ali…[et al.]. Effects of induction therapy with alemtuzumab versus antithymocyte globulin among highly sensitized kidney transplant candidates. Saudi Journal of Kidney Diseases and Transplantation Vol. 27, no. 4 (Jul. / Aug. 2016), pp.665-670.
https://search.emarefa.net/detail/BIM-693015
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Shamsaifar, Ali Rida& Roozbeh, Jamshid& Khajerezae, Thurayya& Nikeghbalian, Saman& Kazimi, Kourosh& Malik Husayni, Sayyid Ali…[et al.]. Effects of induction therapy with alemtuzumab versus antithymocyte globulin among highly sensitized kidney transplant candidates. Saudi Journal of Kidney Diseases and Transplantation. 2016. Vol. 27, no. 4, pp.665-670.
https://search.emarefa.net/detail/BIM-693015
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 669-670
رقم السجل
BIM-693015
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر